Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

The Therapeutic Implications of the Gut Microbiome and Probiotics in Patients with NAFLD.

Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2019 Feb 25;7(1). pii: E27. doi: 10.3390/diseases7010027. Review.

2.

Anti-Diabetic Medications for the Pharmacologic Management of NAFLD.

Cholankeril R, Patel V, Perumpail BJ, Yoo ER, Iqbal U, Sallam S, Shah ND, Kwong W, Kim D, Ahmed A.

Diseases. 2018 Oct 3;6(4). pii: E93. doi: 10.3390/diseases6040093. Review.

3.

When to Initiate Weight Loss Medications in the NAFLD Population.

Yoo ER, Sallam S, Perumpail BJ, Iqbal U, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 30;6(4). pii: E91. doi: 10.3390/diseases6040091. Review.

4.

Judicious Use of Lipid Lowering Agents in the Management of NAFLD.

Iqbal U, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 24;6(4). pii: E87. doi: 10.3390/diseases6040087. Review.

5.

The Role of Vitamin E in the Treatment of NAFLD.

Perumpail BJ, Li AA, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 24;6(4). pii: E86. doi: 10.3390/diseases6040086. Review.

6.

Emerging Therapeutic Targets and Experimental Drugs for the Treatment of NAFLD.

Dibba P, Li AA, Perumpail BJ, John N, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 19;6(3). pii: E83. doi: 10.3390/diseases6030083. Review.

7.

Potential Therapeutic Benefits of Herbs and Supplements in Patients with NAFLD.

Perumpail BJ, Li AA, Iqbal U, Sallam S, Shah ND, Kwong W, Cholankeril G, Kim D, Ahmed A.

Diseases. 2018 Sep 10;6(3). pii: E80. doi: 10.3390/diseases6030080. Review.

Supplemental Content

Loading ...
Support Center